U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Hartley Medical Center Pharmacy, Incorporated - Close Out Letter 9/26/17
  1. Compliance Actions and Activities

CLOSEOUT LETTER

Hartley Medical Center Pharmacy, Incorporated


Recipient:
Hartley Medical Center Pharmacy, Incorporated


United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

Division of Pharmaceutical Quality Operations IV
19701 Fairchild Road
Los Angeles, California 92612
Telephone: (949) 608-2900
Fax: (949) 608-4415 

 
 

VIA UNITED PARCEL SERVICE

September 26, 2017

William Stuart, Owner/President
Hartley Medical Center Pharmacy, Inc.
113 W. Victoria Street
Long Beach, CA 90805-2162

Dear Mr. Stuart:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [WL #29-16] dated April 21, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Acting for CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV